MARKET

AMRN

AMRN

Amarin
NASDAQ
1.280
+0.070
+5.79%
After Hours: 1.270 -0.01 -0.78% 18:31 06/02 EDT
OPEN
1.230
PREV CLOSE
1.210
HIGH
1.280
LOW
1.210
VOLUME
2.35M
TURNOVER
0
52 WEEK HIGH
2.230
52 WEEK LOW
1.040
MARKET CAP
495.88M
P/E (TTM)
-5.6437
1D
5D
1M
3M
1Y
5Y
Catalyst Watch: Apple's WWDC event, OPEC fallout and REITs on display
Seeking Alpha · 1d ago
Amarin gains as heart disorder therapy Vascepa cleared in China
Seeking Alpha · 2d ago
BRIEF-Amarin Partner Eddingpharm Receives Regulatory Approval For Vascepa In Mainland China
Reuters · 2d ago
Validea Kenneth Fisher Strategy Daily Upgrade Report - 5/31/2023
NASDAQ · 3d ago
Amarin Highlights New Data Providing Potential Mechanistic Insight Into Vascepa/Vazkepa Reduction Of Cardiovascular Events
Benzinga · 05/12 15:02
Impel Pharmaceuticals Names Michael Kalb CFO; Shares Fall
Impel Pharmaceuticals Names Michael Kalb CFO; Shares Fall
MT Newswires · 05/10 10:01
Amarin Corp's Return On Capital Employed Insights
Benzinga · 05/09 14:50
Alkermes board declines to endorse any Sarissa nominees
Seeking Alpha · 05/08 22:00
More
About AMRN
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.

Webull offers kinds of Amarin Corporation plc (ADR) stock information, including NASDAQ:AMRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMRN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AMRN stock methods without spending real money on the virtual paper trading platform.